AI assistant
Sending…
Armata Pharmaceuticals, Inc. — Director's Dealing 2017
Sep 11, 2017
34152_dirs_2017-09-11_8b3d5e38-da17-47d5-aa1a-503d9d71385c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AmpliPhi Biosciences Corp (APHB)
CIK: 0000921114
Period of Report: 2017-09-07
Reporting Person: Johnson Wendy S. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-07 | Stock Option (Right to Buy) | $0.91 | A | 10900 | Acquired | 2027-09-06 | Common Stock (10900) | Direct |
More from Armata Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 27
Regulatory Filings
2026
Apr 27
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 23